Complex-I inhibition and oxidative processes have been implicated in the loss of nigral dopamine neurones in Parkinson's disease and the toxicity of MPTP and its metabolite MPP + . Tetrahydrobiopterin, an essential cofactor for tyrosine hydroxylase, may act as an antioxidant in dopaminergic neurones and protects against the toxic consequences of glutathione depletion. Here we studied the effects of manipulating tetrahydrobiopterin levels on MPP + toxicity in organotypic, rat ventral mesencephalic slice cultures. In cultures exposed to 30 lM MPP + for 2 days, followed by 8 days 'recovery' in control medium, we measured dopamine and its metabolites in the tissue and culture medium by HPLC, lactate dehydrogenase release to the culture medium, cellular uptake of propidium iodide and counted the tyrosine hydroxylaseimmunoreactive neurones. Inhibition of tetrahydrobiopterin synthesis by 2,4-diamino-6-hydroxypyrimidine had no significant synergistic effect on MPP + toxicity. In contrast, the tetrahydrobiopterin precursor L-sepiapterin attenuated the MPP + -induced dopamine depletion and loss of tyrosine hydroxylase-positive cells in a dose-dependent manner with 40 lM L-sepiapterin providing maximal protection. Accordingly, increasing intracellular tetrahydrobiopterin levels may protect against oxidative stress by complex-I inhibition.
Mitochondrial dysfunction and oxidative stress, including complex-I deficits and glutathione depletion, have been implicated in the loss of nigral dopamine (DA) neurones in Parkinson's disease (PD) and the selective toxicity of MPTP, its metabolite MPP + (Jenner 1998 ) and rotenone (Betarbet et al. 2000) against these neurones. Dopaminergic neurones grown as primary dissociated cell cultures or as organotypic mesencephalic slice cultures are, however, preferentially resistant to the oxidative stress induced by glutathione depletion, possibly due to high intrinsic levels of tetrahydrobiopterin (BH 4 ) in DA neurones (Nakamura et al. 2000a,b; Gramsbergen et al. 2002) . Tetrahydrobiopterin is an essential cofactor for aromatic amino acid hydroxylases, including tyrosine hydroxylase (TH; Kaufman 1993) , and all three forms of nitric oxide synthase (NOS; Kwon et al. 1989) and may act as an intrinsic antioxidant, in particular as a scavenger of superoxide (Nakamura et al. 2001) . Toxic effects of BH 4 have, however, been reported in a variety of cell lines, including catecholaminergic cells (Choi et al. 2000) . Because of its role as a cofactor for TH, BH 4 was considered for use as an antiparkinsonian drug more than a decade ago. A limited number of PD patients have indeed been treated with BH 4 , but with conflicting results (Dissing et al. 1989 and references therein). However, the possible role of BH 4 as an antioxidant or neuroprotective agent in experimental models of dopaminergic neurodegeneration has not been investigated.
We recently showed that the BH 4 precursor L-sepiapterin provides protection against the toxicity of glutathione depletion in organotypic mesencephalic slice cultures and that inhibition of GTP-cyclohydrolase I, the rate-limiting enzyme of BH 4 synthesis, by 2,4-diamino-6-hydroxypyrimidine (DAHP) makes DA cells vulnerable for glutathione depletion (Gramsbergen et al. 2002) . Since MPP + toxicity has been linked to oxidative stress in DA cells (Fallon et al. 1997; Sriram et al. 1997; Jenner 1998; Klivenyi et al. 2000) , we hypothesized that increasing BH 4 levels by cotreatment with its immediate precursor L-sepiapterin might protect against MPP + toxicity, whereas inhibition of BH 4 synthesis by DAHP would potentiate the toxicity.
Primary dissociated neuronal cell cultures are typically derived from embryonic rat brain. These cultures, lacking glial support in the form of trophic factors and glutathione (Dringen 2000; Mytilineou et al. 1999) , maximally survive for 2 weeks in vitro. Organotypic ventral mesencephalic slice cultures from newborn rat brain, containing the DA neurones of the substantia nigra and the ventral tegmental area, are characterized by a relative preservation of intrinsic neuronal circuitries and functional neurone-glia interactions. Such cultures grow and survive for weeks or months in chemically defined culture media and allow long-term drug treatments and the study of reversible or irreversible trophic or toxic effects (Gähwiler et al. 1997) . As a result of better survival and more advanced developmental stage of DA cells, slice cultures allow monitoring of endogenous DA and its main metabolites 3,4-dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA) over time in the medium as well as in the tissue by HPLC (Studer et al. 1996; Schmidt et al. 1997; Hoglinger et al. 1998; Meyer et al. 2000) .
Here we report the time-and dose-dependent toxicity of MPP + in ventral mesencephalic slice cultures as well as protection against MPP + by the DA uptake inhibitor nomifensine, as shown in vivo (Melamed et al. 1985; Santiago et al. 1995) . Furthermore, the effect of manipulation of intracellular BH 4 on MPP + toxicity was studied by assays of DA and metabolites in culture medium and tissues by measurement of lactate dehydrogenase (LDH) release into the medium and by densitometric measurements of cellular propidium iodide (PI) uptake and counting of TH-immunoreactive cells. A preliminary account of this work has appeared in abstract form (Gramsbergen et al. 2001) .
Materials and methods

Organotypic slice cultures
Slices of ventral mesencephalic tissue were obtained from neonatal rats and grown in organotypic culture using a static interface culture method, essentially as described previously (Stoppini et al. 1991; Meyer et al. 2000) . In some experiments we used nigro-striatal slice cocultures, which were prepared as described previously (Gramsbergen et al. 2002) . Briefly, 350-lm thick slices of ventral mesencephalon were prepared from newborn, post-natal day 0-1 rats under sterile conditions using a tissue chopper (McIlwain tissue chopper; The Mickle Laboratory Engineering Co. Ltd, Gomshall, Surrey, UK), placed in Gey's balanced salt solution (Gibco BRL, Life Technologies Ltd, Paisley, UK) with D-glucose (6.5 mg/mL) at room temperature (18°C) and separated, trimmed for excess tissue and cut into halves at the midline. Five ventral mesencephalic slices from the same hemisection were grown on a semiporous membrane insert (0.3 lm; Millipore Corporation, Bedford, MA, USA) in six-well culture trays containing 1 mL serum-containing medium per well [50% Opti-MEM, 25% horse serum and 25% Hank's balanced salt solution (all from Gibco BRL) supplemented with D-glucose and L-glutamine to final concentrations of 25 and 1 mM, respectively]. Culture trays were placed in an incubator at 36°C with 5% CO 2 . After 3 days in vitro, the culture medium was changed to serum-free Neurobasal medium (Gibco BRL) supplemented with D-glucose (25 mM), L-glutamine (1 mM) and B27 supplement (Gibco BRL), 1 : 50 v/v, containing antioxidants (Brewer et al. 1993) . The cultures were allowed to mature in this medium, which was changed twice a week. No antimitotic drugs or antibiotics were added at any stage. After 3-4 weeks in vitro, and after screening for presence of minimally acceptable levels of DOPAC (> 20 pmol/mL) and HVA (> 50 pmol/mL) in the medium, the slice cultures were used for experimentation. Modulating intracellular BH 4 levels are expected to influence the antioxidant capacity of DA cells. Therefore, the effects of DAHP (5 mM) and L-sepiapterin (10-40 lM) on MPP + toxicity (20-30 lM) were studied in medium without antioxidants (B27 -). The protocol for DAHP and L-sepiapterin experiments was as follows: preexposure with DAHP or L-sepiapterin (3 days), coexposure with MPP + (2 days) and a first recovery period with B27 -medium (2 days), followed by a second recovery period with B27 + medium (2 · 3 days). No drugs were present in the recovery medium.
MPP
Propidium iodide uptake and lactate dehydrogenase efflux As general markers of cell death we used (i) PI uptake by individual slice cultures and (ii) LDH release, measuring LDH accumulated from four to five slice cultures per well. The PI uptake was determined on day 0 (baseline level) and subsequently monitored at different time points (days) during and following drug exposures as described previously Noraberg et al. 1999) . The PI uptake was recorded with a digital camara (Sensys KAF 1400 G2; Photometrics, Tucson, AZ, USA) and quantified using NIH image 1.54 image analysis program.
Medium samples for LDH (90 lL) were collected in coded vials with 10 lL of (10 ·) concentrated Tris/NaCl solution (0.813 M Tris and 2.033 M NaCl, pH 7.2) to maintain a neutral pH and stored at ) 20°C until measured by an automatic spectrophotometric analyser (Cobas Mira plus; Roche Diagnostics AG, Rotkreuz, Switzerland) using pyruvate as a substrate and absorbance of NADH at 340 nm (Vassault 1983) .
HPLC analysis of dopamine, 3,4-dihydroxyphenylacetic acid and homovanillic acid in culture medium and tissue extracts The stability of DA and DOPAC in medium samples is highly dependent on pH and the presence of antioxidants. When neurobasal medium with antioxidant-containing supplement (B27 + ) is buffered with CO 2 (inside the incubator, in the dark), HVA is stable for at least 24 h, whereas the half-life of DA and DOPAC is about 6-8 h.
In neurobasal medium without antioxidants (B27 -) DA and DOPAC decay within 8 h, whereas HVA is stable. In ambient air and daylight (outside the incubator), the pH of neurobasal medium, containing a carbonate-based buffer, rapidly increases (pH > 8.0). Under these conditions DA and DOPAC decay with a half-life of about 2 min, whereas HVA again is more stable with a half-life of 8-10 min. Therefore, rapid acidification with perchloric acid (PCA; pH < 4.0, within 30 s) is necessary to stabilize DA, DOPAC and (to a lesser extent) HVA in neurobasal medium samples.
A volume (500 ll) of culture medium from each well was collected in Eppendorf vials on ice, containing 125 lL 1 M PCA with antioxidants (0.2 g/L Na 2 S 2 O 5 and 0.05 g/L Na 2 -EDTA). Subsequently, samples were centrifuged at 15 000 r.p.m. (20 627 g) for 20 min at 4°C and the supernatant fluid collected (550 lL) and stored at ) 20°C until analysis. Under our chromatographic conditions, injections of the (diluted) medium extracts allowed detection of DOPAC and HVA, but not of DA, because of unknown, coeluting compounds. Therefore, DA in the supernatant fluid was purified by alumina extraction (Anton and Sayre 1962; Westerink et al. 1982; Ganhao et al. 1991) . In brief, 50 mg alumina were put in 5-mL plastic tubes and 500 lL PCA supernatant fluid, 1.0 mL 2 M Tris-buffer, pH 8.6 (60.55 g Tris in 250 mL Milli-Q water, adjusted to pH 8.6 with 100% glacial acetic acid), 80 lL 250 mM EDTA and 20 lL internal standard (2.5 pmol 3,4-dihydroxybenzoic acid) were added. The mixture was shaken (15 min, room temperature) and centrifuged at 1200 r.p.m. (300 g, 5 min, 0°C; Beckman Model J-6M, Beckman, Palo Alta, CA, USA). The supernatant fluid was discarded and the alumina precipitate was resuspended in 3 mL milli-Q water and centrifuged again (300 g, 5 min, 0°C). This washing procedure was repeated three times. Finally, 200 lL 0.1 M PCA were added to the alumina precipitate, the mixture shaken (15 min, 33°C), centrifuged (300 g, 5 min, 25°C) and the supernatant fluid containing the free catecholamines used for HPLC analysis (50 lL).
Tissue samples were prepared as follows. All cultures from each well were transferred from the insert membrane into Eppendorf vials on ice containing 200 lL 0.1 M PCA with antioxidants. Tissue slices were then sonicated, centrifuged at 15 000 r.p.m. (20 627 g) for 20 min at 4°C and the supernatant fluid was collected and stored at ) 20°C until analysis.
Levels of DA, DOPAC and HVA were determined by HPLC with electrochemical detection as described previously (Sloot and Gramsbergen 1995; Gramsbergen et al. 2002) .
Determination of tetrahydrobiopterin
In two parallel series of experiments tissue levels of biopterin (predominantly BH 4 ) were determined after pre-treatment with DAHP or sepiapterin (3 days) and (co)treatment with or without MPP + (2 days). Immediately following drug exposures, ventral mesencephalic (VM) slice cultures were briefly washed (three times) in Hanks balanced salt solution at room temperature and then rapidly removed from the semiporous membranes, frozen on dry ice and kept at )80°C until analysis. Cellular BH 4 was determined after acidic oxidation of the reduced forms by iodine essentially as described previously (Hesslinger et al. 1998; Ziegler 1985) . Briefly, tissue samples were homogenized in Tris buffer and the reduced forms of biopterin oxidized with 1% iodine/2% potassium iodine solution. After protein precipitation by trichloric acid (TCA) and pre-purification by cation exchange chromatography, the samples were analysed by reverse-phase HPLC and fluorescence detection (Ex, 350 nm and Em, 450 nm) using biopterin and neopterin standards.
Tyrosine hydroxylase immunohistochemistry
Cultures not used for HPLC analysis were fixed in 4% paraformaldehyde in phosphate buffer (pH 7.4) for 1 h, transferred to a 20% sucrose solution in phosphate buffer (pH 7.4) for 24 h, frozen on dry ice and 20-lm thick cryostat sections were mounted onto gelatine-coated microscope slides. Immunohistochemical staining for TH was done as described previously (Meyer et al. 2000) . 
Quantification of tyrosine hydroxylase-immunoreactive neurones in cryostat sections
Numbers of TH-immunoreactive neurones per culture well were estimated using an approximated stereological counting technique (West et al. 1991) . Neurones were counted in two ways: (i) neurones with a clearly identifiable nucleus and (ii) neurones with an identifiable nucleus showing at least one process with a minimum length of two times the diameter of the nucleus. All sections (20 lm thickness) were counted using the CAST-Grid System (Olympus, Alberstlund, Denmark). The LDH levels of the culture medium (measured as enzyme activity) were increased by MPP + > 30 lM from 10 to 15 U/L to a maximum of c. 180-220 U/L at day 4, indicating that most cell death occurs in the first recovery period. In the subsequent recovery period, LDH levels declined with almost normal levels at day 10, indicating no further cell loss. Densitometric measurements of cellular PI uptake, obtained in the same experiment, revealed a similar pattern until day 4; PI uptake remained elevated throughout the recovery period. The dose-dependent toxicity of MPP + is clearly illustrated by the depletion of DA tissue levels at day 10 and LDH release and PI uptake at day 4 (Fig. 1) . The DA levels were c. 50% depleted by 20 lM but, because of the large variation in controls, this depletion is not significant. At 30 lM MPP + DA levels were significantly and c. 85% depleted; at this concentration PI uptake and LDH release were also significantly increased. Further DA depletion and PI and LDH increases were observed at 40 and 50 lM MPP + . Consistent with these findings was the significant 71% loss of TH-positive cells by 30 lM MPP + and a normal number of TH-positive cells after treatment with 10 or 20 lM MPP + (data not shown).
Protection by nomifensine
The protective effect of nomifensine (10 lM) on MPP + toxicity is shown by preservation of DA levels in the culture medium and in the tissue (Fig. 2) . Nomifensine treatment alone increased extracellular DA levels almost threefold. Even in the presence of MPP + nomifensine significantly increased DA levels in the medium. In cultures treated with MPP + alone medium DA levels were almost completely depleted by day 4 and did not recover (Fig. 2a) . Analysis of DA tissue contents revealed a complete protection against MPP + toxicity (Fig. 2b) .
Effect of 2,4-diamino-6-hydroxypyrimidine on MPP + toxicity and tetrahydrobiopterin tissue content Inhibition of BH 4 biosynthesis by 5 mM DAHP reduced DA tissue contents significantly by 50% (Fig. 3) . Cotreatment with MPP + (20 lM, 2 days) produced even lower levels of DA (39% of control), which were also significantly different from control. However, the changes in DA levels were not significantly different from those following single DAHP or MPP + treatments. Thus, DAHP treatment had no significant potentiating effect on MPP + toxicity. In addition, cellular BH 4 levels of DAHP-treated cultures were only reduced by 23%, which was not significant (Table 1) .
Effect of L-sepiapterin on MPP
+ toxicity and tetrahydrobiopterin tissue content L-sepiapterin provided significant and dose-dependent protection against MPP + toxicity (30 lM, 2 days exposure, 8 days recovery) as shown by DA metabolite levels in medium ( Fig. 4) , cellular PI iodide uptake (Fig. 5) , DA tissue levels (Fig. 6 ) and the number of TH-immunoreactive cells (Fig. 7 for histology, Fig. 8 for cell counts).
In cultures pre-treated with L-sepiapterin DOPAC and HVA levels were dose-dependently increased with a c. threefold increase by 40 lM sepiapterin. Following single MPP + treatment DOPAC and HVA levels remained depleted until the end of the recovery period in medium with antioxidants (B27 + ). In contrast, DOPAC and HVA levels returned to baseline values in controls and in sepiapterin/ MPP + -cotreated cultures, with best protection by 20 and 40 lM sepiapterin (Fig. 4) . MPP + -induced PI uptake was completely prevented by 20 and 40 lM L-sepiapterin, whereas 10 lM sepiapterin attenuated PI uptake significantly (Fig. 5) . The PI uptake data suggest that L-sepiapterin not only protects against DA cell death but also against MPP + -induced non-DA cell death.
Significant protection against MPP
+ -induced tissue DA depletion (1% of control) was observed with all of the tested L-sepiapterin concentrations. The DA tissue content of cultures cotreated with 40 lM L-sepiapterin reached levels not significantly different from control (70%; Fig. 6 ). This is in agreement with the histological data obtained in another set of experiments showing complete protection by this concentration of L-sepiapterin (Figs 7 and 8) . The BH 4 tissue levels were 18-31-fold increased by treatment with 40 lM L-sepiapterin (Table 1) .
Discussion
The main findings of this study in organotypic nigral slice cultures include the following: (i) a relatively long recovery period (8 days) following MPP + treatment is required to distinguish between reversible and irreversible effects on DA metabolism; (ii) MPP + toxicity is prevented by the DA transport inhibitor nomifensine; and (iii) MPP + toxicity can be attenuated by the BH 4 precursor L-sepiapterin in a dosedependent manner.
The DOPAC and HVA levels in culture medium containing antioxidants (B27 + ) are good indices of the dopaminergic integrity of static interface, rat ventral mesencephalic slice cultures (this study). Accumulation of HVA levels in the feeding medium of organotypic explant cultures of fetal dog ventral mesencephalon (Mytilineou et al. 1983; Schmidt et al. 1997 ) and accumulation of DA levels in organotypic free-floating roller tube cultures of embryonic rat ventral mesencephalon (Studer et al. 1996; Hoglinger et al. 1998) have been reported previously as indices of the dopaminergic integrity of such cultures. A reduction in the levels of DA and metabolites in the culture medium may either indicate a reduction in the number of surviving DA neurones or an inhibition of DA synthesis or release. Our data suggest that MPP + inhibits TH activity at concentrations that may not be sufficient to kill the dopaminergic neurones. An inhibitory effect of MPP + on TH activity has been reported previously in rats using in vivo microdialysis (Matsubara et al. 1995) , in mice after MPTP administration and in vitro using PC12 cells (Ara et al. 1998) . This inactivation of TH has been attributed to tyrosine nitration (Ara et al. 1998) . Although 30 lM MPP + caused > 90% DA depletion, c. 30% of THimmunoreactive neurones were still present after 8 days recovery indicating that, in these remaining neurones, DA function is impaired. In addition, morphological data showed a complete rescue of TH-positive cells by 40 lM sepiapterin (Fig. 8) , whereas DA tissue contents were still reduced by about 30% (Fig. 6 ). This again indicates that DA production is not completely normalized in (a subpopulation of) surviving TH cells. The concentrations of MPP + (20-30 lM) exerting a persistent neurotoxic effect in the present rat slice culture model are about a factor of 10 higher than that used in primary mesencephalic cell culture models (1-5 lM; Leonardi and Mytilineou 1998) but close to that reported by others using organotypic rat cultures (Mytilineou and Cohen 1985; Dickie and Greenfield 1997) . A lack of glia support and the immature, embryonic stage of development in primary cell cultures may account for these differences.
The nomifensine experiments show that, in our in vitro model, MPP + is taken up via the DA transporter. This is in accordance with previous in vivo (Melamed et al. 1985; Santiago et al. 1995) and in vitro studies using synaptosomes (Javitch et al. 1985) or acute slice preparations (Mayer et al. 1986; Martin et al. 1991) . Furthermore, the nomifensine experiments revealed that re-uptake of spontaneously released DA occurs since extracellular DA levels were significantly increased (two-to threefold) by nomifensine. Thus, static interface, organotypic ventral mesencephalic or ventral mesencephalic-striatal (co)cultures provide a convenient research tool to study the neuroprotective and therapeutic potential of novel DA uptake blockers.
Manipulation of exogenous or endogenous BH 4 levels is known to affect DA biosynthesis in rat brain (Miwa et al. 1985; Suzuki et al. 1988 ). In our model system, treatment (Przedborski et al. 1996; Przedborski and Jackson-Lewis 1998) . Interestingly, BH 4 is a cofactor of all forms of NOS but the BH 4 precursor L-sepiapterin does not exacerbate MPP + toxicity but, in contrast, provides strong protection in the present slice culture model. Previously, it has been shown that BH 4 protects against NO toxicity in NOS-containing PC12 cells (Koshimura et al. 1998) .
With low BH 4 levels the NOS reaction becomes uncoupled, causing O 2 -AE and peroxynitrite formation (Cosentino et al. 1998) . In patients with sepiapterin reductase deficiency, increased sepiapterin may competitively inhibit NOS and further uncouple the NOS reaction (Jones et al. 2001; Zorzi et al. 2002) . Apparently, in the present nigral slice culture model, addition of sepiapterin does not cause neurotoxicity but, in contrast, protects against neurotoxicity, indicating that it is rapidly converted to BH 4 .
Apart from cofactor and scavenging functions for BH 4 , BH 4 has been reported to stimulate PC12 cell proliferation. Furthermore, PC12 cell proliferation after exposure to epidermal growth factor or nerve growth factor requires elevation of intracellular BH 4 and activation of its initial biosynthetic enzyme GTP cyclohydrolase I (Anastasiadis et al. 1996; Stegenga et al. 1996; Anastasiadis et al. 1997) . In addition, glial-derived neurotrophic factor (GDNF) up-regulates GTP-cyclohydrolase I activity and BH 4 levels in ventral mesencephalic organotypic free-floating roller tube cultures (Bauer et al. 2002) . Neurotrophic factors, such as GDNF, exert a protective potential against 6-hydroxydopamine-induced DA cell loss (Choi-Lundberg et al. 1997; Rosenblad et al. 2000) . An up-regulation of BH 4 by GDNF may thus not only affect the DA biosynthetic pathway (i.e. TH activity) but could also provide protection against oxidative damage (this study). However, the effects of BH 4 on cell survival and apoptosis are still confusing. Recently, Anastasiadis et al. (2001) reported that BH 4 accelerates apoptosis in undifferentiated PC12 cells deprived of serum and in differentiated neurone-like PC12 cells after nerve growth factor withdrawal. Previously, it was reported that BH 4 enhanced survival of differentiated PC12 cells following serum and nerve growth factor deprivation (Koshimura et al. 1999) . This discrepancy may be explained by proliferation of apoptosis-resistant PC12 cells in the presence of BH 4 . It has been hypothesized that BH 4 , in the presence of trophic support, increases cell cycle progression and thereby cell growth whereas, in the absence of trophic support, it acccelerates DNA fragmentation and PC12 cell death (Anastasiadis et al. 2001) . Apparently, in rat nigral slice culture, with its relatively mature dopaminergic neurones, sufficient trophic support is available, possibly from surrounding glial or target cells.
In conclusion, we have established an organotypic, neonatal rat slice culture model for PD based on MPP + treatment and a long recovery period. The potent protective effect of sepiapterin against MPP + toxicity in this model suggests that, under pathological conditions with complex-I inhibition, increasing intracellular BH 4 levels may provide protection for dopaminergic neurones. The pathophysiological role of BH 4 and the potential of sepiapterin therapy should now be investigated in other in vitro and in vivo models for PD.
